Jim Corrigan Named Chief Executive Officer of ConnectiveRx

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Harbor Point at Centerville Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third • Brothers to Host Grand Opening Event for JDog Junk Removal & Hauling Business on April 28th • Suzano 2023 annual report on Form 20-F • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion • United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™ • LENNAR NOW SELLING THREE NEW-HOME COLLECTIONS AT JUNIPERS, SAN DIEGO'S RESORT-STYLE COMMUNITY FOR ACTIVE ADULTS AGED 55 AND BETT • Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Emmy-winning Cyberchase Expands Digital Presence to Engage Every Kid, Everywhere Ahead of Season 15 Premiere • Disneyland Resort Celebrates Return of Pixar Fest for a Limited Time, April 26-Aug. 4, 2024 • Cabot Park Village Senior Living Community Named One of the Country's Best by U.S. News & World Report • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report • Dual Enrollment Helps High School Students Launch Rewarding Careers • United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52% • Coastal Carolina, Southwestern Law School, and Other Institutions Streamline Accessibility Workflows With YuJa's PDF Remediation • Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third St • Chestnut Park at Cleveland Circle Assisted Living Community Named One of the Country's Best by U.S. News & World Report • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer&rs

Jim Corrigan Named Chief Executive Officer of ConnectiveRx

WHIPPANY, N.J. , April 22 /Businesswire/ - The ConnectiveRx Board of Managers today announced that President Jim Corrigan has been named Chief Executive Officer of the company, an industry-leading provider of technology-enabled patient support and access solutions for specialty and branded medications, effective immediately. Corrigan succeeds Harry Totonis, who has been named Chairman of the Board of Managers and will lead strategic partnerships, investments and M&A strategy in that position. Additionally, Chief Commercial Officer Frank Dana will expand his role to President and Chief Commercial Officer, continuing to lead business development and network partnerships for the company.

As a member of the Strategic Advisory Board of Genstar Capital, ConnectiveRx’s majority shareholder, Harry Totonis, working with Genstar, established ConnectiveRx in 2015. During his tenure as CEO, he has guided the company through three successful acquisitions, expanded the company’s services to support the entire patient medication journey, and accelerated organic growth from 200 to 1700 employees. Today, ConnectiveRx partners with more than 120 pharmaceutical manufacturers and supports over 530 pharmaceutical brands.

“Under Harry’s leadership and strategic foresight, he has grown a family-owned copay business into an industry-leading pharmaceutical services company that is revolutionizing how patients access and afford specialty medications. We look forward to continuing to work with Harry as a member of our Strategic Advisory Board and in his new role as Chairman of the Board at ConnectiveRx,” said Eli Weiss and Jean-Pierre Conte, Managing Directors of Genstar Capital.

Prior to ConnectiveRx, Jim Corrigan’s 30+ year career is highlighted by his most recent role as President and CEO of ERT, a clinical trial technology provider. Under his leadership, ERT quadrupled in size. Jim also served a long tenure as CEO of surgery products for GE’s multi-million-dollar life sciences division.

“Jim has an excellent track record of leadership in the life sciences industry driving transformative growth across both publicly and privately owned organizations. Our leadership styles are complementary and our priorities of delivering superior patient, customer and employee experiences are consistent, which is why he is the right person to lead ConnectiveRx as the next CEO.”

Jim Corrigan added, “I joined ConnectiveRx because I believe in the company’s mission of helping patients access and afford their medications. I’m honored to partner with Harry and lead our great team through its next chapter of growth while continuing to deliver on the company’s dedication to innovation, exceptional customer partnership and patient service.”

About ConnectiveRx

ConnectiveRx takes the pain out of the prescription process for pharmaceutical manufacturers, healthcare providers and their patients. Through a technology-driven platform of patient support, affordability, awareness and adherence solutions for branded and specialty medications, the company is a strategic partner that helps navigate the complex prescription journey for more than 84 million patients and 1.6 million healthcare providers each year.

ConnectiveRx is headquartered in both Whippany, NJ and Pittsburgh, PA. To learn more, visit www.connectiverx.com or follow us on Twitter, LinkedIn and Facebook @ConnectiveRx.